Riskpilot← Back to searchSign inGet full accessMICRONOVA AS
ASActiveOrg 985349541Rabekkgata 15, 1523 MossWholesale of pharmaceutical and medical goods · NACE 4646Est. 20031 employeeswww.micronova.no
Revenue 2024
NOK 833K
+55% vs 2023
EBITDA margin
4.2%
+193% vs 2023
Equity ratio
64.9%
Financial strength
Net profit 2024
NOK 23K
+159% vs 2023
| Revenue | NOK 833K | +55% |
| EBITDA | NOK 35K | +193% |
| Net profit | NOK 23K | +159% |
| Total assets | NOK 601K | -7% |
| Equity | NOK 390K | +6% |
| Employees | 1 | — |
Legal name
MICRONOVA AS
Org number
985349541
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. februar 2003
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Handel, agenturvirksomhet, og annen virksomhet som dermed står i forbindelse, kjøp og salg og drift av fast eiendom, samt annen virksomhet med økonomisk formål, herunder deltagelse i andre selskaper med samme eller lignende formål.
Address
Rabekkgata 15, 1523 Moss
Website
www.micronova.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 496 | 1 830 | 1 091 | 539 | 833 |
| Staff expenses | −143 | −286 | −286 | −90 | −68 |
| EBITDA | −220 | −15 | 67 | −37 | 35 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −220 | −15 | 67 | −37 | 35 |
| Net financials | −6 | −20 | −9 | −1 | −12 |
| Profit before tax | −226 | −35 | 58 | −39 | 23 |
| Tax | −22 | −0 | −0 | −0 | −0 |
| Net profit | −204 | −35 | 58 | −39 | 23 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 905 | 1 022 | 710 | 647 | 601 |
| Equity | 383 | 348 | 406 | 368 | 390 |
| Long-term debt | 249 | 249 | 0 | 0 | 0 |
| Short-term debt | 274 | 425 | 303 | 280 | 211 |
| Total debt | 523 | 674 | 303 | 280 | 211 |
EBITDA margin
4.2%
This company
15.8%
Market median
-73% vs market
20202024
Equity ratio
64.9%
This company
38.2%
Market median
+70% vs market
20202024
Return on equity
5.8%
This company
18.4%
Market median
-68% vs market
20202024
Net profit margin
2.7%
This company
8.1%
Market median
-67% vs market
20202024
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
20202024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2005 | |
| Deputy Chairman | 2005 | |
| Chairman | 2005 | |
| Board of Directors | 2005 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MICRONOVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Øyvind Steffensen | Board of Directors | 0 companies |
| Hanne Steffensen | Deputy Chairman | 0 companies |
| Pål Christian Steffensen | Chairman | 0 companies |
| Espen Steffensen | Board of Directors | 0 companies |